Inspiration Healthcare Share Discussion Threads

[strollingmolby] 11/8/2021 15:13

Looking forward to it kicking off again this weekend, and seeing Virgil and Konate at the back (& Gomez..). Not sure we have enough to win it but it'll be close. City, Utd and Chelsea look strong so hopefully there is a signing or two to be signed yet to bolster the squad.

Anyway back to IHC - on target for 150p in short order and an ATH :)

[lfc4ever] 11/8/2021 14:39

Hi, Jan. What are your thoughts for the season?

[strollingmolby] 11/8/2021 08:34

Nice trading update, and forward looking statement - steady as she goes. 47% up on the last H1 gives almost £21m revenue, and if continued could bring the FY up to £54m. Very nice.

[peter27] 25/6/2021 09:40

Nice AGM statement

[vprt] 15/6/2021 09:32

My guess is that tip-buyers are cooling off. And trend-followers can be similarly quick to jump off the bandwagon when they fear the trend is broken, moving on to the next hot thing. Just guessing.

As I'd like to increase my small holding, preferably at lower prices, I would welcome a further dip. So please feel free to join the sellers if you're feeling nervous...

A further hypothetical cause - completely out of thin air on my side (but consistent with their strategy and past) - could be that they are lining up more major M&A and are preparing a placing.

[lfc4ever] 15/6/2021 09:10

what's going on?

[melloteam] 20/5/2021 14:47

Just to let shareholders and prospective investors know that Inspiration Healthcare Group plc, ANGLE plc, Polarean Imaging plc, Diaceutics and IBT will be presenting at Mello Events’ Healthcare webinar on the 25th May at 5:30pm-9:30pm. The webinar will also include the latest insights and analysis from investment managers, research professionals, analysts and experienced investors. If you are a shareholder and you would like a ticket to the Healthcare event, please use the code SHVIP75 to receive 75% off your ticket.
Additionally, on the 24th May, The Property Franchise Group PLC and Samarkand will be presenting at the MELLOMonday webinar event on 24th May at 6pm-9:30pm. There will also be special insights from Michael Taylor (@shiftingshares): Using technical analysis to find trades.
There will be over 600 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions including the popular Mello BASH (Buy, Avoid, Sell or Hold).
If you purchase a ticket to MELLOMonday, you will automatically get sent a link to the healthcare event! Tickets are still available and if you would like one at half price then enter the code MMTADVFN50.

[davidosh] 19/5/2021 16:23

Just to let you all know that the company are presenting at Mello Healthcare next week

[xtrmntr] 08/5/2021 14:33

Crawley-based Inspiration Healthcare (IHC:120p), a fully integrated medical technology company with a strong focus on the high-growth neonatal intensive care market, has posted a major earnings beat on all levels.With the company's gross margin five percentage points higher than Cenkos Securities 43.6 per cent forecast, and annual revenues more than doubling to £37m, gross margin of £18m was £2.1m above analysts' estimates and operating profit of £4.3m was almost 50 per cent higher, too. Adjusted earnings per share (EPS) of 6.9p increased 90 per cent year on year, and net cash of £10.7m (15p a share) was almost double forecasts. Last summer's acquisition of SLE, a designer and maker of ventilators for neonatal intensive care, contributed £9.4m to revenue and there were £7.3m of one-off Covid-19 ventilators orders, too, but underlying revenue still increased 14 per cent. There is every reason to expect the positive trend to continue.In the past seven weeks, the company has received regulatory approval in Japan and China for its enhanced top-of-the-range SLE6000 neonatal ventilator that includes features such as enhanced High Frequency Oscillatory Ventilation (designed for use with critically ill infants) and the OxyGenie ® patented oxygen control algorithm (helps maintain infants at their targeted oxygen saturation levels). The higher-margin product has already received £650,000 of orders and chief executive Neil Campbell says that the two territories generated £2.8m-worth of orders with the old model, suggesting decent growth to come from the current base. SLE received a Queens Award for Enterprise this week in recognition of its work in developing an infant ventilator with the OxyGenie closed-loop software algorithm. It can only help boost sales.Sensibly, Inspiration is investing £2m in new facilities which will be operational this autumn to support additional growth capacity. The company is also making progress with its patented non-invasive, non-pharmaceutical respiratory device for apnoea of prematurity, aiming to sell it next year into a target market affecting 1.5m babies annually in the US, Europe and Japan.I suggested buying the shares, at 75p, last autumn (Alpha Research: 'Profit from a medical technology winner', 27 October 2020), and on an enterprise valuation of 12.5 times cash profit estimates, I see ample upside to my 150p target. Buy.

[shauney2] 21/4/2021 13:16

A very positive move into China.
IHC have recieved approval and an immediate order from its distributor in China worth approximately £250,000for neonatal ventilator.Delivery during May 2021.

Neil Campbell, Chief Executive Officer, commented

"We are delighted that SLE has received approval for the SLE6000 in what is potentially one of our largest markets and also to announce that we have hit the ground running with a large order for immediate delivery.China represents a significant growth opportunity for the Group"

[nakedmolerat] 24/3/2021 15:26

Profit taking after the tip has snowballed today

[sphere25] 23/3/2021 08:31

That explains the stream of buying

[penpont] 23/3/2021 08:14

Simon Thompson commented on IHC yesterday in IC, concluding:

'Inspiration’s share price has kicked on 39 per cent since I highlighted the investment opportunity at 90p (‘Five small-caps with earnings upgrade tailwinds’, 2 February 2021), and is 67 per cent higher than when I initiated coverage, at 75p (Alpha Research: ‘Profit from a medical technology winner’, 27 October 2020). Trading on a trailing cash-adjusted price/earnings (PE) ratio of 20, Inspiration’s growth potential is still not yet fully priced in and I raise my target price to 150p. Buy.'

[cockerhoop] 16/3/2021 15:57

Looks ahead of schedule, Cenkos only had £500k (50 units) as a medium term target.

[shauney2] 16/3/2021 15:33

Good to see their recent acquisition SLE Ltd has received initial order of £400k from Japan for the new SLE6000 neonatal ventilator.

[cheshire man] 04/3/2021 17:05

Naked Trader bought DYOR

[le4r] 04/3/2021 16:46

Nice surprise to see the share price today - anyone know what happened here?

[doobz] 17/2/2021 11:49

Anyone got any targets in mind for this one?

[tizo100] 12/2/2021 21:40

Pratt2
how many times has Robbie Burns aka the Naked Trader stated not to list his high risk share on these bulletin boards people have registered and paid him for these high risk tips.

[doobz] 11/2/2021 14:23

Hi Pratt, where did you read this about NT buying? Not in diary? either way awesome rise and I bought in the mid 80's

[mginvestor] 11/2/2021 12:48

thanks Pratt, I did check his website but it doesnt say he did and that was updated yesterday?

[pratt2] 11/2/2021 12:43

Bought by the naked trader yest. Target price 200

[strollingmolby] 11/2/2021 12:16

Hi - I found this article that was issued a week ago...



Inspiration Healthcare’s neonatal care drives hefty upgrades

Operating profit estimates upgraded 18 per cent.
SLE acquisition delivers increasing sales.

Crawley-based Inspiration Healthcare (IHC:90p), a fully integrated medical technology company with a strong focus on the high growth neonatal intensive care market, is reaping the benefits of last summer’s £18m complementary acquisition of SLE, a designer and manufacturer of four types of ventilators for neonatal intensive care. SLE always looked like a good fit. That’s because Inspiration’s range of neonatal respiratory products support and assist the care of preterm infants by providing resuscitation, stabilisation and respiratory support.

SLE’s sales have increased steadily since the deal completed in July, partly due to one-off Covid-19 orders but also reflects other factors such as cross-selling opportunities across the enlarged group (neonatal respiratory disposables and breathing circuits, for example). Inspiration’s directors note that the operational savings identified at the time of the acquisition are being achieved. The addition of SLE’s 30,000 sq. ft. facility in Croydon for the assembly of technically advanced capital equipment means that Inspiration now has 50,000 sq. ft. of manufacturing capacity. Inspiration is now less reliant on third party products, too.

Moreover, with Inspiration’s annual revenue set to more than double to at least £36.5m (3 per cent ahead of forecasts) on a gross margin of around 43.6 per cent, then a higher proportion of incremental margin earned drops through to profit given Inspiration’s relatively fixed cost base. This explains why house broker Cenkos Securities has raised its operating profit estimate by 18 per cent to £2.86m, an 88 per cent year-on-year increase. On this basis, Cenkos expects adjusted EPS of 5.9p, up from 3.8p in the 2019/20 financial year, and closing net cash of £5.4m (8p a share).

The SLE acquisition was one reason why I suggested buying the shares, at 75p (Alpha Research: ‘Profit from a medical technology winner’, 27 October 2020), noting that the enlarged business is well placed to benefit from organic growth trends in overseas markets while reaping synergy benefits across a wider customer base. Those dynamics are still at play. So, with the shares priced on a modest cash-adjusted forward PE ratio of 13.5, I maintain my 105p target price. Buy.